Rhythm Pharmaceuticals Inc (RYTM)

Currency in USD
88.30
+3.07(+3.60%)
Closed·
After Hours
85.84-2.46(-2.79%)
·

RYTM Earnings

Latest Release
May 07, 2025
EPS / Forecast
-0.81 / -0.6734
Revenue / Forecast
32.70M / 40.70M
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
06/2025--/-0.67--/43.75M----Free Sign Up
03/2025-0.81/-0.67332.7M/40.7M-20.29%-19.66%Free Sign Up
12/2024-0.72/-0.7441.83M/36.04M+2.7%+16.07%Free Sign Up
09/2024-0.73/-0.833.25M/32.42M+8.75%+2.56%Free Sign Up
06/2024-0.55/-0.70929.08M/28.79M+22.42%+1.01%Free Sign Up
03/2024-2.35/-2.3525.97M/27.02M0%-3.89%Free Sign Up
12/2023-0.7/-0.724.2M/25.63M0%-5.58%Free Sign Up
09/2023-0.76/-0.7622.5M/22.17M0%+1.49%Free Sign Up
06/2023-0.82/-0.819.2M/14.8M-2.5%+29.73%Free Sign Up
03/2023-0.92/-0.7211.45M/12.14M-27.78%-5.68%Free Sign Up

All numbers in USD

Rhythm Pharmaceuticals Inc Earnings Call Summary for Q1/2025

  • Rhythm Pharmaceuticals reported Q1 2025 GAAP EPS of -$0.81, missing estimates of -$0.6734; revenue fell short at $37.72M vs $40.7M forecast
  • Net product revenues grew 45% YoY to $11.7M; company ended Q1 with $314.5M cash, projecting runway into 2027
  • Preparing Q3 filing for cetmelanotide in acquired hypothalamic obesity following positive Phase III results
  • FY2025 revenue forecast at $183.41M, rising to $290.95M for FY2026; non-GAAP operating expenses projected $285M-$315M
  • Stock rose 0.59% pre-market despite earnings miss; analysts target $65-$94 range, suggesting potential upside
Last Updated: 07/05/2025, 14:42
Read Full Transcript

FAQ

What Is Rhythm Pharma's Earnings Per Share (TTM)?

The Rhythm Pharma EPS (TTM) is -2.82.

When Is The Next Rhythm Pharma Earnings Date?

Rhythm Pharma will release its next earnings report on 04 Aug 2025.

What Is Rhythm Pharma’s Revenue Forecasts For Upcoming Quarters?

Rhythm Pharma’s revenue forecast is 43.75M.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.